AI filing briefs · archive

8-K filings in August 2026, explained

2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

2,515 of 2,914 briefs match

newest first · times in ET · page 1 of 51

Global Water Resources amends Northern Trust credit line, raising limit to $30.0 million

Neutral financing Written later 1.012.03

Global Water Resources, Inc. entered into an eighth modification of its revolving line of credit with The Northern Trust Company on August 28, 2026. The amendment extends the maturity to August 30, 2028 and raises the maximum borrowing to $30.0 million, though it drops to $25.0 million if the company completes any capital market activity such as an equity or debt offering.

  • Maximum borrowing rises from $20.0 million to $30.0 million under the revolving line of credit.
  • Scheduled maturity extended from May 18, 2028 to August 30, 2028.
  • Borrowing limit falls to $25.0 million if the company raises funds through any equity or debt offering after the amendment date.
  • Agreement dated August 28, 2026; the 8-K was signed August 31, 2026 by CFO Michael J. Liebman.
Read the filing on SEC.gov ↗
NIXXNixxy, Inc. Aug 31, 5:36 PM ET

Nixxy terminates CFO MeiLin Yu effective immediately; successor not yet named

Neutral leadership Written later 5.02

Nixxy, Inc. said its Board of Directors terminated the employment of Chief Financial Officer MeiLin Yu on August 28, 2026, effective immediately. The company has identified a potential successor and will file a new 8-K once that person is appointed, so shareholders do not yet know who will lead finance.

  • CFO MeiLin Yu's employment was terminated by the Board on August 28, 2026, effective immediately.
  • The company says a potential successor has been identified, but no name or appointment date is given.
  • The filing does not state the reason for the termination.
  • A follow-up Current Report on Form 8-K will be filed after the successor is appointed.
Read the filing on SEC.gov ↗
DGIIDIGI INTERNATIONAL INC Aug 31, 5:26 PM ET

Digi International Expands Senior Secured Revolving Credit Facility to $350 Million

Positive financing Written later 1.011.022.037.01

On August 27, 2026, Digi International entered into an amended and restated $350 million senior secured revolving credit agreement with BMO Bank N.A. as administrative agent. The new facility replaces a $250 million agreement dated December 7, 2023, which Digi paid off and terminated, and it matures on August 27, 2031. The company says the expanded capacity and lower pricing give it more financial flexibility for acquisitions, though the filing does not report any earnings or cash flow figures.

  • $350 million senior secured revolving facility, with an uncommitted accordion of the greater of $130 million or 100% of trailing four-quarter EBITDA, maturing August 27, 2031.
  • Replaces the $250 million revolving credit agreement dated December 7, 2023, which was paid off and terminated on August 27, 2026.
  • Term SOFR margins range from 1.25% to 2.625%, compared with 135 to 310 basis points under the prior facility, according to the press release.
  • Maximum total net leverage covenant increased from 3.0x to 3.50x; minimum interest coverage ratio of 3.00x is unchanged.
Read the filing on SEC.gov ↗
COLDAMERICOLD REALTY TRUST Aug 31, 5:26 PM ET

Americold closes $1.3 billion cold storage joint venture with EQT

Positive m&a Written later 1.012.017.01

Americold closed its joint venture with EQT's Active Core Infrastructure fund on August 31, 2026, contributing 12 cold storage facilities valued at more than $1.3 billion. Americold received approximately $1.1 billion in net cash proceeds, which it intends to use to repay outstanding debt, and it will hold a 30% stake and serve as day-to-day manager. Shareholders face a capped contingent income support obligation of up to $70 million over the term.

  • Joint venture closed August 31, 2026; EQT holds 70% and Americold holds 30% of Americold-EQT Cold Storage Partnership, LLC
  • Approximately $1.1 billion in net cash proceeds, expected to be used to repay outstanding indebtedness
  • Income support arrangement capped at up to $70 million over the 10-year term
  • Joint venture obtained mortgage financing of up to $863.5 million, of which $845.5 million was drawn at closing
Read the filing on SEC.gov ↗
TDWTIDEWATER INC Aug 31, 5:23 PM ET

Tidewater completes $500 million acquisition of Wilson Sons Ultratug, adding 22 PSVs

Neutral m&a Written later 1.012.012.037.01

Tidewater completed its acquisition of Wilson, Sons Ultratug and affiliate Atlantic Offshore Services effective August 31, 2026, for an aggregate purchase price of $500 million on a debt-free, cash-free basis. The company paid about $283.1 million in cash and assumed about $229.3 million of existing target debt, and it took on new guarantee and liquidity obligations tied to the target's BNDES loans.

  • Tidewater paid approximately $283.1 million in cash and acquired the targets subject to about $229.3 million of existing debt; the price remains subject to a post-closing adjustment.
  • Tidewater procured unsecured bank guarantees from DNB Bank ASA of up to $170,458,000 and must maintain minimum liquidity of at least 1.25x the outstanding Replacement LCs.
  • Tidewater must use best endeavors to replace or repay BNDES parent company guarantees before December 31, 2026; the BNDES construction loans total about $170.1 million outstanding.
  • The deal adds a fleet of 22 PSVs, and the company's BB Loan guarantee was replaced by Tidewater at closing, with the BB Loan outstanding principal of about $22.5 million.
Read the filing on SEC.gov ↗
TGENTECOGEN INC. Aug 31, 5:23 PM ET

Tecogen files S-3 to register resale of 4,507,603 shares by selling stockholders

Neutral shareholder Written later 8.01

Tecogen filed a Form S-3 registration statement covering the resale of 4,507,603 common shares by selling stockholders who acquired them in private placements. The trustees of Hatsopoulos family trusts holding 3,475,714 of those shares signed lock-up agreements restricting sales for 182 calendar days after the SEC declares the registration effective.

  • Registration covers resale of 4,507,603 shares of common stock, $.001 par value, by selling stockholders.
  • Trusts holding 3,475,714 of the shares signed lock-up agreements dated August 31, 2026.
  • Lock-up restricts sales for 182 calendar days from the date the SEC declares the registration statement effective.
  • Offers and sales may not be made by selling stockholders until the SEC declares the registration effective.
Read the filing on SEC.gov ↗
SSMSono Group N.V. Aug 31, 5:22 PM ET

Sono Group signs non-binding letter of intent to combine with Sports One

Mixed m&a Written later 1.018.01

Sono Group N.V. signed a non-binding letter of intent on August 31, 2026, to combine with Sports One, a newly formed sports intelligence and sports franchise investment business, and sold 283,500 ordinary shares to private purchasers at market price. Sports One's existing equityholders would own a super-majority of the combined public company, and completion depends on definitive agreements, due diligence and shareholder approval, so there is no assurance the deal will close.

  • Share purchase of 283,500 ordinary shares, equal to 19.9% of outstanding ordinary shares, at the prior day's Nasdaq closing bid price, with a 180-day lock-up for purchasers
  • Proceeds are for working capital and general corporate purposes; the company agreed not to use them to repay debt (with limited exceptions) or to redeem shares
  • Sports One's existing equityholders would own a super-majority of the combined company, which is expected to be renamed Sports One
  • YA II PN, Ltd., the sole holder of the company's preferred shares, granted affiliates of Sports One a call option on approximately half of those shares (700 preferred shares subject to the option)
Read the filing on SEC.gov ↗
JAZZJazz Pharmaceuticals plc Aug 31, 5:21 PM ET

Jazz Pharmaceuticals closes $1.25 billion exchangeable senior notes offering due 2032

Neutral financing Written later 1.012.033.028.01

On August 31, 2026, Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, closed a $1.25 billion private offering of 1.875% exchangeable senior notes due September 15, 2032, including the full $150.0 million option. The company also repurchased about $225.0 million of its ordinary shares from note purchasers at $249.29 per share, paid from cash on hand under its July 2024 repurchase program, which reduces the remaining authorization. For shareholders, the filing adds a senior unsecured debt obligation guaranteed by the company and sets an exchange price of about $355.24 per share.

  • Notes total $1.25 billion in principal, carry a 1.875% interest rate, and mature September 15, 2032; the closing includes the full $150.0 million option.
  • Estimated net proceeds are approximately $1,226.4 million, which the company expects to use for general corporate purposes.
  • Initial exchange price is about $355.24 per ordinary share, a premium of about 42.5% over the August 26, 2026 closing price.
  • About $225.0 million of ordinary shares were repurchased at $249.29 each, the August 26, 2026 closing price, using existing cash on hand.
Read the filing on SEC.gov ↗
KSSKOHLS Corp Aug 31, 5:20 PM ET

Kohl's names Ryan Waymire chief merchandising officer, replacing Nick Jones

Neutral leadership Written later 5.027.01

Kohl's said Nick Jones, its Chief Merchandising Officer, will leave effective October 1, 2026, and named Ryan M. Waymire, a former Walmart U.S. senior vice president of fashion, to succeed him effective September 28, 2026. Waymire will lead Kohl's overall merchandise strategy and all merchandising functions, reporting to CEO Michael J. Bender. The filing reports a leadership change in a key role but no financial results, guidance or dollar figures.

  • Nick Jones departs effective October 1, 2026; he is entitled to separation benefits under his March 20, 2023 Executive Compensation Agreement
  • Ryan M. Waymire accepted the role on August 27, 2026, effective September 28, 2026
  • Waymire previously held roles at Walmart U.S., Wayfair, FabFitFun, Amazon and Target, including nearly a decade at Target
  • The announcement was made in a press release dated August 31, 2026 (Exhibit 99.1)
Read the filing on SEC.gov ↗
KYNBKYNTRA BIO, INC. Aug 31, 5:18 PM ET

Kyntra Bio cuts royalty financing cap to $65 million with $42.6 million upfront payment

Mixed financing Written later 1.012.037.01

Kyntra Bio amended its royalty financing agreement with NQ Project Phoebus, L.P., lowering the maximum aggregate payments from $125 million to $65 million in exchange for a $42.6 million accelerated upfront payment. The company says the amendment and the FibroGen Europe bankruptcy together reduce its future liabilities by approximately $80 million, but pro forma cash, cash equivalents, investments, and accounts receivable fall to $53.1 million from $95.7 million as of June 30, 2026.

  • Maximum aggregate payments reduced from $125 million to $65 million, a $60 million reduction in payment obligations
  • $42.6 million upfront payment brings total payments to NQ Project Phoebus to $50 million, a full return of its invested capital
  • Remaining $15 million cap to be paid from 50% of Astellas revenue for EVRENZO sales in Europe and other Astellas territories excluding Japan
  • Pro forma cash and related balances of $53.1 million as of June 30, 2026; company expects cash runway into the fourth quarter of 2027
Read the filing on SEC.gov ↗
EAFGRAFTECH INTERNATIONAL LTD Aug 31, 5:15 PM ET

GrafTech to permanently close Monterrey, Mexico graphite electrode plant

Mixed restructuring Written later 2.05

GrafTech approved a plan on August 6, 2026 to permanently cease manufacturing at its Monterrey, Mexico facility, and began notifying affected employees on August 31, 2026. The company estimates one-time cash costs of $20 million to $25 million, mostly expected by the end of 2027, and says the closure is meant to better align capacity with market conditions and reduce its cost structure.

  • Board approved closure of the Monterrey Facility on August 6, 2026; employee notifications began August 31, 2026
  • Production expected to conclude early in the second quarter of 2027, with phased wind-down subject to Mexican legal and labor obligations
  • Estimated one-time cash costs of $20 million to $25 million, including about $10.0 million for environmental and closure costs and $11.5 million for severance
  • Connecting pin production will rely on the Pamplona, Spain facility after the closure
Read the filing on SEC.gov ↗
JVACOFFEE HOLDING CO INC Aug 31, 5:15 PM ET

Coffee Holding restores CEO Gordon's $450,000 salary, drops $1.6 million bonus

Neutral leadership Written later 5.02

Coffee Holding's compensation committee approved and the company and CEO Andrew Gordon signed Amendment No. 2 to his employment agreement, which restores his base salary to $450,000 a year retroactive to February 1, 2026. The amendment reverses Amendment No. 1, which had cut his salary to $80,000, and provides a make-whole payment for the salary difference. It also eliminates a $1.6 million incentive bonus that Amendment No. 1 would have paid if he stayed through January 1, 2030, which affects the company's future compensation costs for its chief executive.

  • Base salary restored to $450,000 per year, effective February 1, 2026, reversing the prior cut to $80,000.
  • Make-whole payment due as soon as practicable after signing, covering the salary he would have received since February 1, 2026 at the $450,000 rate; the filing does not state a total amount.
  • Incentive bonus of $1.6 million under Amendment No. 1, payable if employed through January 1, 2030, is eliminated.
  • Committee approved the amendment August 29, 2026; executed August 31, 2026; full text filed as Exhibit 10.1.
Read the filing on SEC.gov ↗
OKEONEOK INC /NEW/ Aug 31, 5:09 PM ET

ONEOK to buy Brazos Midland assets for $4.425B; Apollo to invest $9B

Mixed m&a Written later 1.013.027.018.01

ONEOK agreed to acquire Brazos Midstream's Permian Midland Basin assets for $4.425 billion in cash and signed a contribution agreement with an Apollo affiliate for a $9 billion minority equity investment. ONEOK says the deal reduces debt by about $5 billion and lowers expected pro forma 2027 leverage to about 3.25 times debt-to-EBITDA, but the Apollo investment carries a Class B return and distribution rights that will affect cash flow available to common shareholders.

  • Brazos Midland acquisition for $4.425 billion in cash, expected to close in the fourth quarter of 2026, subject to Hart-Scott-Rodino clearance.
  • Apollo investment of $9 billion for a Class B interest in ONEOK Holdings, with a 7.0% IRR cap for the first nine years; expected to close in the first half of September 2026.
  • About $5 billion of debt to be extinguished, with a tender offer capped at $2 billion, an early tender deadline of September 14, 2026 and an expiration of September 29, 2026.
Read the filing on SEC.gov ↗
BTCKTeucrium Commodity Trust Aug 31, 5:04 PM ET

Teucrium BTCK Fund Reaches 50,000-Share Minimum; Redemptions Below It Will Be Rejected

Negative shareholder Written later 8.01

The sponsor of Teucrium Commodity Trust reported that the 7RCC Spot Bitcoin and Carbon Credit Futures ETF has reached its minimum outstanding level of 50,000 Shares, equal to five baskets of 10,000 Shares each. Until new creation orders raise the share count, the sponsor will reject redemption orders that would push outstanding Shares below that minimum, which may reduce market maker willingness to trade and widen bid-ask spreads.

  • Outstanding Shares reached the 50,000-Share minimum (five baskets of 10,000 Shares each).
  • Redemption orders that would reduce outstanding Shares below 50,000 will be rejected until additional creation orders are received.
  • Filing warns that wider bid-ask spreads and reduced liquidity on NYSE Arca could cause Share prices to deviate more than usual from NAV per Share.
Read the filing on SEC.gov ↗

Westlake Chemical Partners names Tommy E. Darby chief accounting officer

Neutral leadership Written later 5.02

Westlake Chemical Partners LP appointed Tommy E. Darby as Vice President and Chief Accounting Officer of its general partner, effective immediately. He succeeds Jeffrey A. Holy, who moves to Vice President, Finance and Investor Relations. The change affects the partnership's senior accounting leadership, though the filing discloses no financial results or compensation terms.

  • Tommy E. Darby, age 45, appointed Vice President and Chief Accounting Officer effective August 31, 2026
  • Darby previously served as Vice President and Chief Accounting Officer of Pactiv Evergreen Inc. (now Novolex) from August 2022 to April 2025
  • Jeffrey A. Holy moves to Vice President, Finance and Investor Relations, succeeding Darby's predecessor role
Read the filing on SEC.gov ↗
IVZInvesco Ltd. Aug 31, 5:01 PM ET

Invesco to retire Asia Pacific head Andrew Lo; Marty Franc to succeed him in 2027

Neutral leadership Written later 5.027.01

Invesco Ltd. said Andrew Lo, Senior Managing Director and Head of Asia Pacific, will retire on March 31, 2027, after 32 years with the firm. Marty Franc, currently CEO for Australia, Greater China and Southeast Asia, will succeed him as head of Asia Pacific during the first quarter of 2027, after a transition period. The filing does not report any financial figures, so the change affects shareholders mainly through leadership of a region the company calls a significant contributor to its global business.

  • Andrew Lo retires March 31, 2027, after 32 years with Invesco, and steps down as head of Asia Pacific on a date in Q1 2027 to be determined.
  • Marty Franc, who will be based in Hong Kong, has more than 30 years of asset management experience, including 13 years at Invesco.
  • Lo will become Chairman Emeritus, Asia Pacific, serving on the China and India joint venture boards and providing strategic counsel; the agreement with Lo has not yet been executed.
  • CEO Andrew Schlossberg said Franc is the right leader to build on the Asia Pacific foundation.
Read the filing on SEC.gov ↗
INHDINNO HOLDINGS INC. Aug 31, 5:00 PM ET

Inno Holdings CFO Mengshu Shao resigns; Mei Wang named interim CFO

Neutral leadership Written later 5.02

Inno Holdings said CFO and director Mengshu Shao resigned effective August 25, 2026, with the company stating the departure was not due to any disagreement on operations, policies or practices. The board filled her board seat with Junsheng Chen and named Accounting Manager Mei Wang as interim Chief Financial Officer, with both appointments effective August 25, 2026.

  • Mengshu Shao resigned as Director and Chief Financial Officer effective August 25, 2026, with no disagreements disclosed.
  • Junsheng Chen, Vice President of subsidiary ApexVest Holdings Limited, was appointed Director and will be offered a one-time $10,000 bonus.
  • Mei Wang, Accounting Manager of subsidiary Lear Group Limited, was appointed interim Chief Financial Officer until a permanent CFO is named.
  • Both new appointees signed indemnification agreements with the company on August 26, 2026.
Read the filing on SEC.gov ↗
SONMDNA X, Inc. Aug 31, 4:59 PM ET

DNA X regains Nasdaq stockholders' equity compliance; faces one-year panel monitor

Mixed legal/regulatory Written later 8.01

DNA X, Inc. received a letter on August 28, 2026, from a Nasdaq Hearings Panel saying the company has regained compliance with the $2.5 million stockholders' equity requirement. The company's securities remain subject to delisting if it fails to maintain compliance with all Nasdaq listing rules through November 18, 2026, and it is under a mandatory panel monitor until August 28, 2027. If the company falls below the equity requirement again during that period, it would get no compliance plan or extra time, and its securities could be delisted.

  • Panel determined the company regained compliance with the $2.5 million stockholders' equity requirement; letter dated August 28, 2026
  • Securities remain subject to delisting if the company fails to maintain compliance with all Nasdaq rules until November 18, 2026
  • Mandatory panel monitor runs until August 28, 2027; a new equity deficiency would lead to a delisting determination with no cure period
Read the filing on SEC.gov ↗
BTCKTeucrium Commodity Trust Aug 31, 4:57 PM ET

Teucrium Wheat Fund may invest in KC and MGEX wheat futures as alternatives

Neutral product/contract Written later 8.01

The sponsor of Teucrium Commodity Trust said its Teucrium Wheat Fund (WEAT) may now invest in Kansas City Hard Red Winter wheat futures and Minneapolis Hard Red Spring wheat futures. The fund would use these alternatives only if position limits, accountability levels or price fluctuation limits on its benchmark wheat futures restrict its ability to hold the amounts it needs. The filing warns that these contracts may cause the fund's net asset value to track its benchmark less closely and that these markets are less liquid.

  • Change is effective immediately; the fund's investment objective, benchmark and benchmark component futures contracts are unchanged.
  • Alternative contracts are KC HRW Wheat futures on the Chicago Board of Trade and HRS Wheat futures on the Minneapolis Grain Exchange.
  • Allocation to alternatives is at the sponsor's sole discretion, with holdings in the same contract months as existing benchmark component positions.
  • A Rule 424(b)(3) prospectus supplement was filed August 31, 2026, to be read with the prospectus dated April 30, 2026.
Read the filing on SEC.gov ↗

Victory Capital agrees to acquire First Eagle; $3.5 billion term loan committed

Neutral m&a Written later 1.013.02

On August 25, 2026, Victory Capital entered a merger agreement to acquire First Eagle from Seller, a partnership majority owned by Genstar Capital affiliates, paying a mix of cash, newly issued common stock equal to 4.9% of outstanding shares after closing, and new non-voting convertible preferred stock. Closing depends on regulatory approvals, Victory Capital stockholder approval, and client consents, and either party may terminate if closing has not occurred by May 25, 2027, so shareholders face both dilution and deal risk.

  • Merger agreement signed August 25, 2026 with GC Ferry Parent, L.P. (Seller) and GC Ferry Holdings, Inc. (First Eagle)
  • Stock consideration: newly issued common shares representing 4.9% of outstanding common stock after closing, plus Series B non-voting convertible preferred stock
  • Credit commitments of up to $3.5 billion incremental term loan, $200.0 million revolving facility and $950.0 million secured bridge loan from Bank of America and RBC
  • Closing requires stockholder approval; if not obtained, share issuance is capped at 19.9% of common stock and the balance is paid in cumulative perpetual preferred stock
Read the filing on SEC.gov ↗
MTUSMetallus Inc. Aug 31, 4:47 PM ET

Metallus CEO Michael Williams to retire; President Kristopher Westbrooks named successor

Neutral leadership Written later 5.027.01

Metallus CEO Michael Williams plans to retire as CEO and resign from the Board effective December 31, 2026, and the Board has named President and Chief Operating Officer Kristopher Westbrooks as his successor effective January 1, 2027. The filing describes the change as the result of a succession planning process and does not report any financial results or guidance.

  • Williams retires as CEO and director effective December 31, 2026, and will be a non-executive Special Advisor through June 30, 2027, at a monthly base salary of $39,375 with no new incentive awards.
  • Westbrooks, age 48, becomes President and CEO and a director effective January 1, 2027; he has been President and COO since June 2025 and was previously CFO after joining in September 2018.
  • Westbrooks' base salary rises to $800,000 per year, his target annual award rises from 85% to 100% of base, and his target long-term equity grant rises to $2.4 million per year beginning in 2027.
  • Kevin A. Raketich moves from Executive Vice President and Chief Commercial Officer to Executive Vice President, Strategy and Corporate Development.
Read the filing on SEC.gov ↗
MVSTMicrovast Holdings, Inc. Aug 31, 4:46 PM ET

Microvast receives Nasdaq notice over bid price below $1, has 180 days to cure

Negative legal/regulatory Written later 3.01

Microvast Holdings received a Nasdaq notice on August 26, 2026, saying its common stock closed below the $1 minimum bid price for 30 consecutive trading days. The shares remain listed and trading on Nasdaq, and the company has 180 days to regain compliance before any delisting process would begin, which shareholders should watch closely.

  • Notice received August 26, 2026, under Nasdaq Rule 5450(a)(1) for average closing bid price below $1 over 30 consecutive trading days
  • Common stock continues to trade on Nasdaq; a non-compliance indicator will appear on NASDAQ.com
  • Company has 180 days to regain compliance, subject to possible additional time
  • If not compliant, a delisting notice is expected; an appeal to a Nasdaq Hearings Panel could keep shares listed, but success is not assured
Read the filing on SEC.gov ↗
CPTCAMDEN PROPERTY TRUST Aug 31, 4:38 PM ET

Camden Property Trust: Executive Vice Chairman D. Keith Oden retires, signs separation deal

Neutral leadership Written later 1.015.02

Camden Property Trust said Executive Vice Chairman D. Keith Oden retired effective August 31, 2026, and will remain on the Board of Trust Managers. A Separation and Release Agreement terminated his employment agreement and provides payments tied to amounts he would have received in February 2027, credited to a deferred compensation account. The filing does not state the dollar value of those payments.

  • D. Keith Oden retired as Executive Vice Chairman effective August 31, 2026, and continues as a board member.
  • His employment agreement was terminated under a Separation and Release Agreement with the company and Camden Development, Inc.
  • Payments reflect amounts he would have been eligible to receive in February 2027, credited to a cash deferral account under the Non-Qualified Deferred Compensation Plan.
  • The filing does not disclose the dollar amount of the payments; the agreement is filed as Exhibit 10.1.
Read the filing on SEC.gov ↗
UPSUNITED PARCEL SERVICE INC Aug 31, 4:37 PM ET

UPS Names Wilfredo Ramos to Succeed Kate Gutmann as International Head Effective Sept. 1

Neutral leadership Written later 5.027.01

UPS said Executive Vice President Kate Gutmann will retire from her current roles effective September 1, 2026, and remain in a transitional role through March 31, 2027. Wilfredo Ramos was appointed to succeed her, alongside a new global operating model that reassigns several executive responsibilities. The filing does not include financial results, so it gives shareholders no new performance figures.

  • Kate Gutmann retires from current roles effective September 1, 2026; transitional role through March 31, 2027
  • Wilfredo Ramos appointed EVP and Chief International, Healthcare and Supply Chain Solutions Officer, with over 20 years at the company
  • Nando Cesarone becomes EVP and Chief Global Operations Officer; retention RSU award valued at $6.0 million
  • Bala Subramanian receives retention RSU award valued at $3.0 million; RSUs vest 25% in 2027, 25% in 2028, 50% in 2029
Read the filing on SEC.gov ↗
TDOCTeladoc Health, Inc. Aug 31, 4:35 PM ET

Teladoc Health names Michael Grasher chief financial officer, effective immediately

Neutral leadership Written later 5.027.01

Teladoc Health hired Michael Grasher as its Chief Financial Officer effective August 31, 2026, filling a role that Chief Executive Officer Charles Divita, III had held on an interim basis. Mr. Grasher previously served as CFO of IFG Companies from February 2024 to September 2025 and held CFO roles at Fortegra Group and AMERISAFE, Inc. The filing sets out his base salary, sign-on bonus, equity award and severance terms.

  • Annual base salary of $550,000 and a one-time sign-on bonus of $500,000
  • New-hire equity award with an aggregate target value of approximately $3,000,000, expected to be issued September 1, 2026, split 50% restricted stock units and 50% performance stock units
  • Annual bonus target of 85% of base salary, beginning with respect to 2027
  • Severance if terminated without cause or resigning for good reason outside a change of control: 12 months of base salary; 18 months if within 12 months after a change of control
Read the filing on SEC.gov ↗

Frontier to return 13 A320neo jets early; non-cash charges of $60 million to $80 million

Mixed restructuring Written later 2.058.01

Frontier Airlines, a subsidiary of Frontier Group Holdings, agreed on August 25, 2026 to end leases on 13 A320neo aircraft roughly six to seven years early, with the aircraft returned in the second half of 2026. The company expects about $260 million lower operating lease assets and liabilities, plus charges of $60 million to $80 million (non-cash) and $90 million to $120 million (cash), which will weigh on reported results in 2026 and beyond.

  • Early Return Agreement dated August 25, 2026 covers 13 A320neo aircraft currently in operation, to be returned in the second half of 2026.
  • Expected reduction of about $260 million in both operating lease right-of-use assets and operating lease liabilities.
  • Non-cash charges of $60 million to $80 million and cash charges of $90 million to $120 million, mostly recognized in Q3 and Q4 2026; most cash to be settled in 2028 and 2029.
  • On August 29, 2026, Frontier agreed with AerCap Holdings N.V. to direct lease 10 A321neo aircraft, with deliveries expected from Q4 2026 to Q1 2027.
Read the filing on SEC.gov ↗
FDSFACTSET RESEARCH SYSTEMS INC Aug 31, 4:30 PM ET

FactSet amends credit agreement, extends maturities and raises revolver to $1.5 billion

Neutral financing Written later 1.012.03

On August 28, 2026, FactSet amended its credit agreement with PNC Bank as administrative agent. The amendment extends the term loan maturity to August 28, 2029 and the revolving facility maturity to August 28, 2031, while increasing revolving commitments from $1.0 billion to $1.5 billion. For shareholders, the filing shows expanded and longer-dated borrowing capacity, though the filing does not state any borrowing drawn under the facilities.

  • Revolving commitments increased from $1.0 billion to $1.5 billion, with final maturity extended to August 28, 2031
  • Term loan facility of $375 million, with final maturity extended to August 28, 2029 and scheduled amortization removed
  • Credit spread adjustment of 0.10% removed for Daily Simple SONIA and Term SOFR borrowings
Read the filing on SEC.gov ↗

Charter CFO Jessica Fischer to step down October 15; Kevin Howard named interim

Neutral leadership Written later 5.027.01

Charter Communications said CFO Jessica Fischer will leave the role on October 15, 2026, to pursue another opportunity, and that the resignation was not due to any disagreement with the company or its board. Chief Accounting Officer and Controller Kevin Howard will serve as interim CFO, and the company has started a search for a permanent successor. Charter said it has not changed its previously provided financial outlook or financial policy.

  • Jessica Fischer notified the company of her resignation on August 28, 2026, and will serve through October 15, 2026.
  • Kevin D. Howard, 57, was appointed interim CFO by the board on August 30, 2026, effective October 15, 2026.
  • Howard is currently Executive Vice President, Chief Accounting Officer and Controller, and previously served as interim CFO from August 1 to October 31, 2010.
  • Charter has not changed its previously provided financial outlook or financial policy and has begun a search for a new CFO.
Read the filing on SEC.gov ↗
NUTXNutex Health Inc. Aug 31, 4:25 PM ET

Nutex Health discloses cyberattack; data stolen, hacker threatens to post it

Negative legal/regulatory Written later 1.05

Nutex Health said an unauthorized third party accessed and took information from its servers, including patient, employee, provider, and business data, and has threatened to post it publicly. A class action lawsuit was filed August 27, 2026, and the company says it cannot predict the outcome or estimate the impact on its finances or stock price.

  • Unauthorized party accessed and exfiltrated data; third party has threatened to post it externally
  • Purported class action Haley v. Nutex Health, Case No. 4:26-cv-07197, filed August 27, 2026, in the U.S. District Court for the Southern District of Texas
  • To date, no material impact identified on business operations or financial reporting systems
  • Company intends to make required notifications, including to impacted patients
Read the filing on SEC.gov ↗
ADTADT Inc. Aug 31, 4:24 PM ET

ADT Inc. subsidiaries add $100 million in term A loans under existing credit agreement

Neutral financing Written later 1.012.03

ADT Inc.'s subsidiaries borrowed $100 million of incremental first lien senior secured term A loans on August 28, 2026, under an amendment to their existing term loan credit agreement. Total term A loans outstanding rise to $520,312,500, and the company says the proceeds will fund general corporate purposes.

  • Incremental term A loans of $100,000,000 incurred on August 28, 2026, under Incremental Assumption and Amendment Agreement No. 2
  • Total first lien senior secured term A loans outstanding are $520,312,500 after the borrowing
  • Proceeds will be used for general corporate purposes; the borrowers' obligations under the existing agreement are unchanged
  • Fifth Third Bank, National Association, is administrative agent
Read the filing on SEC.gov ↗
PCTPureCycle Technologies, Inc. Aug 31, 4:15 PM ET

PureCycle extends $200 million revolving credit facility to September 2028

Neutral financing Written later 1.012.03

PureCycle Technologies amended its $200 million revolving credit facility on August 28, 2026, extending the maturity date from September 30, 2027 to September 30, 2028. The company must also pay a maturity extension fee, and the filing does not state its amount.

  • Revolving Credit Facility of up to $200 million extended from September 30, 2027 to September 30, 2028
  • Company must pay a maturity extension fee under the Twelfth Amendment; the fee amount is not stated in the filing
  • Lenders Sylebra Capital Partners Master Fund and Sylebra Capital Menlo Master Fund are greater than 5% beneficial owners of the company
Read the filing on SEC.gov ↗
FRMIFermi Inc. Aug 31, 4:15 PM ET

Fermi Inc. Sets October 30, 2026 Annual Meeting; Lee McIntire Named CEO

Neutral leadership Written later 5.088.01

Fermi Inc. set October 30, 2026 as the date of its first annual stockholder meeting, with an August 31, 2026 record date and a September 10, 2026 deadline for stockholder proposals and director nominations. The filing also discloses that independent director Lee McIntire was appointed Chief Executive Officer effective August 11, 2026, and that Jeffrey Stein joined the Audit Committee on August 25, 2026.

  • Annual meeting set for October 30, 2026; record date is August 31, 2026
  • Stockholder proposals under Rule 14a-8 and director nominations must be received by September 10, 2026
  • Lee McIntire appointed CEO effective August 11, 2026, and resigned from the Audit Committee
  • Jeffrey Stein appointed to the Audit Committee effective August 25, 2026
Read the filing on SEC.gov ↗
CRWSCROWN CRAFTS INC Aug 31, 4:11 PM ET

Crown Crafts dismisses KPMG, hires Grant Thornton as auditor for fiscal 2027

Neutral other Written later 4.01

Crown Crafts' Audit Committee approved dismissing KPMG LLP as independent auditor effective August 27, 2026, and engaging Grant Thornton LLP for the fiscal year ending March 28, 2027, following a competitive proposal process. KPMG's audit reports for fiscal 2025 and 2026 contained no adverse opinion, disclaimer, or qualification, but the filing discloses one reportable event: a material weakness in controls over review and approval of manual journal entries, which the company says was remediated as of March 29, 2026.

  • Audit Committee approved the change on August 27, 2026, after a competitive proposal process.
  • KPMG's audit reports for fiscal years ended March 29, 2026 and March 30, 2025 had no adverse opinion, disclaimer, or qualification.
  • Material weakness first reported in the 10-K filed June 25, 2025 was reported as remediated as of March 29, 2026, in the 10-K filed June 24, 2026.
  • KPMG's letter to the SEC dated August 31, 2026 is filed as Exhibit 16.1.
Read the filing on SEC.gov ↗
ARRYArray Technologies, Inc. Aug 31, 4:09 PM ET

Array Technologies completes $165 million acquisition of Affordable Wire Management

Positive m&a Written later 7.018.01

Array Technologies said it completed its acquisition of Affordable Wire Management, LLC (AWM), a provider of wire management and balance-of-system products for solar and energy storage projects, on August 31, 2026. Buyer paid cash consideration of approximately $165 million, net of customary adjustments and subject to final post-closing settlement. The company expects the deal to be at least high single digit accretive to Adjusted EPS in the first year before synergies.

  • Acquisition of AWM completed August 31, 2026 under a purchase agreement dated July 16, 2026
  • Cash consideration of approximately $165 million, subject to final post-closing settlement
  • Expected to be at least high single digit accretive to Adjusted EPS in the first year before synergies
  • Kevin G. Hostetler is CEO of Array; Scott Rand and Dan Smith, AWM co-founders, join as leaders of the combined business
Read the filing on SEC.gov ↗
RPDRapid7, Inc. Aug 31, 4:07 PM ET

Rapid7 Board Adds Two Directors as Four Members Resign

Neutral leadership Written later 5.02

Four Rapid7 directors resigned from the Board effective August 27, 2026, and the Board elected Maria Barrett and Julian Waits as directors effective September 1, 2026. Chief Experience Officer Julian Waits moves to a non-executive role and the company set a transition agreement under which he remains in a non-executive capacity until December 31, 2026.

  • Resigning directors: Michael Burns, Benjamin Holzman, Thomas Schodorf and Reeny Sondhi, effective August 27, 2026; the filing says the resignations were not due to any disagreement with the company.
  • Board appointed J. Benjamin Nye as Lead Independent Director effective August 27, 2026, succeeding Marc Brown; the Board fixed its size at nine.
  • Resigning directors received cash equal to Policy compensation through June 30, 2027, plus accelerated vesting of unvested director equity awards, as an exception to the director compensation policy.
  • Waits' transition agreement, dated August 30, 2026, provides a transition payment of six months of base salary and continued vesting of his equity awards, subject to a noncompetition covenant.
Read the filing on SEC.gov ↗
GBXGREENBRIER COMPANIES INC Aug 31, 4:06 PM ET

Greenbrier CEO Tekorius to retire; Brian Comstock named successor effective Jan. 6, 2027

Neutral leadership Written later 5.02

Greenbrier CEO and President Lorie Tekorius will retire effective January 6, 2027, and will not stand for re-election as a director at the 2027 annual meeting. The Board appointed Brian J. Comstock, currently Executive Vice President and President, The Americas, as her successor, effective the same date. The filing does not state financial results or changes to guidance, so the direct effect on shareholders is the change in top leadership.

  • Lorie Tekorius retires as CEO and President effective January 6, 2027, and will provide transition services afterward.
  • Brian J. Comstock, 64, appointed to succeed her as CEO and President, effective January 6, 2027.
  • Comstock has worked at Greenbrier since 1998 and has served as Executive Vice President & President, The Americas, since January 2024.
  • Board appointment was made August 26, 2026; the press release was issued August 31, 2026.
Read the filing on SEC.gov ↗
PMVPPMV Pharmaceuticals, Inc. Aug 31, 4:06 PM ET

PMV Pharma reports 46% ORR in updated rezatapopt ovarian cancer interim data

Positive product/contract Written later 8.01

PMV Pharmaceuticals reported updated interim ovarian cancer data for rezatapopt from the Phase 2 pivotal portion of its PYNNACLE trial, with a 46% overall response rate among 76 evaluable patients. The company said recent FDA feedback supports submitting a new drug application for accelerated approval in platinum-resistant or refractory ovarian cancer in the first quarter of 2027, which sets a timeline for shareholders to track.

  • Overall response rate of 46% (35 of 76 patients) as of a May 14, 2026 data cutoff; median duration of response was 10.0 months
  • Company anticipates submitting an NDA for accelerated approval in the first quarter of 2027
  • Discontinuation due to treatment-related adverse events was 5%; full update on all Phase 2 cohorts planned for the fourth quarter of 2026 at a medical conference
Read the filing on SEC.gov ↗
COHNCohen & Co Inc. Aug 31, 4:05 PM ET

Cohen & Co amends $5 million note to insider-linked investor, due August 2027

Neutral financing Written later 1.011.02

Cohen & Company's operating subsidiary replaced a $5,145,926.67 senior promissory note with a $5,000,000 amended and restated note held by JKD Capital Partners I LTD, an entity owned by board member Jack J. DiMaio, Jr. and his spouse. The new note carries 10% annual interest payable quarterly and matures August 31, 2027, with a higher 11% rate after an event of default.

  • Amended and restated note in the principal amount of $5,000,000, combining $2,625,409.50 of unpaid original principal and interest with $2,374,590.50 of new cash from the investor.
  • Interest accrues at 10% per year, payable in cash quarterly beginning November 30, 2026; principal due August 31, 2027.
  • Note cannot be prepaid before January 31, 2027; afterward, prepayment requires at least 31 days' written notice and carries no penalty.
  • The note is senior to the subsidiary's existing indebtedness, and the subsidiary may not take on new debt senior to it after August 31, 2026.
Read the filing on SEC.gov ↗
MYEMYERS INDUSTRIES INC Aug 31, 4:05 PM ET

Myers Industries sells Myers Tire Supply unit for $30 million

Neutral m&a Written later 1.017.01

Myers Industries agreed on August 31, 2026 to sell all membership interests in Myers Tire Supply, its North American tire supply distribution business, to TAPS Holdings, LLC, for $30 million, subject to customary post-closing adjustments. The company says the sale advances its transformation toward engineered resin and composite products and strengthens its balance sheet, though the filing gives no financial results for the business.

  • Consideration is $30 million, subject to post-closing adjustments for cash, indebtedness, net working capital and transaction expenses.
  • The buyer is TAPS Holdings, LLC; the press release identifies it as Lion Equity Partners, a Denver-based private equity firm.
  • Myers has agreed to non-competition and non-solicitation restrictions for 36 months after closing, with carve-outs for certain subsidiaries and Patch Rubber Company.
  • The buyer obtained a buyer-side representation and warranty insurance policy at its own expense.
Read the filing on SEC.gov ↗
CWHCamping World Holdings, Inc. Aug 31, 4:05 PM ET

Camping World Holdings amends $175 million mortgage facility, extends maturity to 2031

Neutral financing Written later 1.012.03

Camping World Holdings' subsidiaries entered into an amended and restated senior secured mortgage credit agreement with M&T on August 25, 2026, totaling $175.0 million in aggregate principal. The new facility replaces the prior facility and extends its maturity from October 27, 2027 to August 25, 2031, adding borrowing capacity and new loan terms for shareholders to track.

  • Facility totals $175.0 million: $132.8 million funded at closing and $42.2 million of delayed draw commitments available through February 25, 2031.
  • About $20.8 million was drawn at closing, net of fees and lender holdbacks, and the borrowers may request up to an additional $100.0 million.
  • Maturity extended to August 25, 2031, from October 27, 2027; amortization of 5.0% of original principal annually begins September 30, 2026.
  • Loans bear interest at term SOFR plus 2.30% or a base rate plus 1.30%, and require a debt service coverage ratio of at least 1.10 to 1.00.
Read the filing on SEC.gov ↗

Worthington Enterprises extends $500 million revolving credit facility to August 31, 2031

Neutral financing Written later 1.012.03

Worthington Enterprises amended and restated its five-year, $500 million revolving credit facility on August 31, 2026, extending the final maturity from September 27, 2028 to August 31, 2031. The company had no borrowings and no letters of credit outstanding under the new agreement at the effective date, and the filing does not describe any change to commitment size, which remains $500 million.

  • Aggregate commitments remain $500 million; maturity extended to August 31, 2031
  • Company may request up to $300 million in incremental commitments or term loans, subject to lender consent
  • No borrowings or letters of credit outstanding as of August 31, 2026
  • Financial covenants: interest coverage at least 3.25 to 1.00; debt-to-capital no greater than 55%
Read the filing on SEC.gov ↗
BBIOBridgeBio Pharma, Inc. Aug 31, 3:54 PM ET

BridgeBio Signs Voluntary U.S. Government Agreement on Medicine Access and Pricing

Neutral legal/regulatory Written later 8.01

BridgeBio entered a voluntary agreement with the U.S. government to expand Medicaid access to Attruby through the GENEROUS Model and lower drug costs. The company says it does not expect to be subject to future pricing mandates, and the specific terms remain confidential.

  • Agreement expands state Medicaid access to Attruby via the GENEROUS Model; specific terms are confidential
  • BridgeBio does not expect future pricing mandates; pricing commitments for future medicines are expected to exclude medicines approved exclusively for orphan indications
  • ForgingBridges copay program is unaffected and can reduce out-of-pocket costs to as little as $0 per month
  • Pending FDA reviews include BBP-418 (PDUFA November 27, 2026) and encaleret (PDUFA May 7, 2027)
Read the filing on SEC.gov ↗
UTMDUTAH MEDICAL PRODUCTS INC Aug 31, 1:33 PM ET

Utah Medical Unit Femcare Buys UK Device Maker Orion Medical Supplies

Neutral m&a Written later 7.01

Utah Medical Products said its subsidiary Femcare Ltd has bought all common shares of Orion Medical Supplies Ltd, a private UK maker and distributor of harm reduction medical devices. The company expects Orion to add about $6 million to its annual consolidated sales, and the purchase was paid from cash reserves.

  • Femcare Ltd purchased all common shares of Orion Medical Supplies Ltd, announced August 31, 2026
  • Purchase price was £3.6 million, paid from cash reserves
  • Orion is expected to add about $6 million to UTMD's current consolidated annual sales
  • Orion operations will move into Femcare's existing Romsey, UK facilities after a transition period
Read the filing on SEC.gov ↗
BOKFBOK FINANCIAL CORP Aug 31, 11:00 AM ET

BOK Financial posts Q2 2026 net income of $176.5 million, or $2.92 per diluted share

Positive earnings Written later 7.01

BOK Financial filed an August 2026 investor presentation furnished under Regulation FD, which includes second-quarter 2026 results and an updated full-year 2026 outlook dated 07/21/26. Net income and diluted earnings per share rose from the prior quarter and the prior year, and the company reported no provision for credit losses in the quarter.

  • Q2 2026 net income was $176.5 million, or $2.92 per diluted share, versus $155.8 million, or $2.58, in Q1 2026 and $140.0 million, or $2.19, in Q2 2025.
  • Period-end loans grew $896 million, or 3.4% sequentially, to $27.1 billion; net charge-offs were $500 thousand.
  • The 2026 outlook as of 07/21/26 projects net interest income of $1.42 to $1.45 billion and fees and commissions of $820 to $845 million.
  • The company expects a 2026 efficiency ratio of about 62%, compared with 65.1% in 2025.
Read the filing on SEC.gov ↗

Albany International CFO Willard Station starts medical leave; controller named acting CFO

Neutral leadership Written later 5.027.01

Albany International's Chief Financial Officer, Willard Station, began a medical leave of absence effective August 31, 2026, with no end date set. The board named Controller and Chief Accounting Officer Sean Valashinas acting principal financial officer in addition to his current role, and the filing states there are no changes to his compensation.

  • Willard Station, CFO and principal financial officer, began medical leave effective August 31, 2026; duration not determined
  • Sean Valashinas, age 55, appointed acting principal financial officer effective August 31, 2026
  • Valashinas has been Controller and Chief Accounting Officer since June 9, 2025; no compensation changes disclosed
  • Company issued a press release on August 31, 2026 announcing the leave and appointment (Exhibit 99.1)
Read the filing on SEC.gov ↗

Choice Hotels names interim CEO Dominic Dragisich as president and CEO, effective Aug. 31

Neutral leadership Written later 5.02

Choice Hotels appointed Dominic Dragisich, its interim CEO since May 20, 2026, as president and CEO and as a director, effective August 31, 2026. Former President and CEO Patrick Pacious resigned from the board on the same date, ending his transitional advisory role. The filing sets out a $1,000,000 base salary and enhanced severance terms for Dragisich, which shareholders may track in future proxy disclosures.

  • Dragisich, age 44, was previously Chief Financial Officer from March 2017 to September 2023 and has been interim CEO since May 20, 2026.
  • Base salary of $1,000,000, short-term incentive target of 150% of base salary, and a minimum 2027 long-term incentive award value of at least $4,000,000.
  • One-time restricted stock unit award with a grant date value of $1,000,000, cliff vesting on the third anniversary of the grant date.
  • Severance agreement amended: lump sum severance of 200% of base salary and bonus, rising to 250% on a Change in Control Termination.
Read the filing on SEC.gov ↗
DTCXDatacentrex, Inc. Aug 31, 8:30 AM ET

Datacentrex Invests $30 Million for 10.5% Stake in Eagle LNG Equity Holder

Neutral m&a Written later 1.018.01

On August 27, 2026, Datacentrex agreed to buy 23,076,923 Class A Common Units of ELNG Equity LLC for about $30 million, and the deal closed on August 28, 2026. The company said the units represent a 10.5% equity interest in Eagle LNG Partners, an LNG producer that supplies fuel for U.S. space launch vehicles. The units are unregistered, illiquid and non-controlling, with no public market, and the filing warns of possible loss of all or part of the investment.

  • Purchase price of about $30 million for 23,076,923 Class A Common Units of ELNG Equity LLC, closed August 28, 2026
  • Press release says the stake is 10.5% equity interest in Eagle LNG, priced at the same value per unit as a concurrent $10 million commitment by an affiliate of The Energy & Minerals Group
  • Units have no public market, carry transfer restrictions, and the company has limited influence over Eagle LNG management and strategy
  • Purchase agreement gives Datacentrex a most favored nations right for three months and a pro rata participation right in ELNG debt financing for 12 months
Read the filing on SEC.gov ↗
CVKDCadrenal Therapeutics, Inc. Aug 31, 8:29 AM ET

Cadrenal Therapeutics says FDA agreed on Phase 3 endpoint and placebo control for CAD-1005

Positive legal/regulatory Written later 7.018.01

Cadrenal Therapeutics said that at a Type D meeting with the U.S. Food and Drug Administration held July 28, 2026, the company and the FDA aligned on key aspects of the protocol and Statistical Analysis Plan for a Phase 3 registrational study of CAD-1005 in heparin-induced thrombocytopenia (HIT). The filing says the agreement sets the primary endpoint definition and the use of a placebo control, which the company says clarifies the regulatory path, but it does not disclose financial results, costs, or a trial start date.

  • Type D meeting with the FDA held July 28, 2026; the company announced the feedback on August 31, 2026.
  • Primary endpoint measures the proportion of Serotonin Release Assay-positive participants with adjudicated new or worsening composite thromboembolic events through Day 14 or hospital discharge.
  • The FDA agreed to a placebo control, with standard anticoagulation therapeutics in both the CAD-1005 and placebo arms.
  • The company states that approximately 50,000 patients in the U.S. have acute HIT each year.
Read the filing on SEC.gov ↗
XPONExpion Energy, Inc. Aug 31, 8:05 AM ET

Expion Energy names Robert Winspear CFO as three directors resign

Neutral leadership Written later 5.025.087.01

Expion Energy appointed Robert Winspear as Chief Financial Officer effective August 25, 2026, replacing Shawna Bowin, who gave notice on July 29, 2026 and will stay on through approximately October 31, 2026. Three directors resigned between August 26 and August 28, 2026, and the board added Marc Jarvis as a director and Scott Burell as chairman, so shareholders face a new finance chief and a reshaped board.

  • Robert Winspear, age 61, became CFO, Secretary and Treasurer on August 25, 2026, with an annual base salary of $285,000 that rises to $300,000 after the 2026 Form 10-K is timely filed.
  • Directors Brian Schaffner and Tien Q. Nguyen resigned effective August 26, 2026; Joseph Hammer resigned effective August 28, 2026. The company said none of the resignations involved a disagreement.
  • Marc Jarvis joined the board on August 28, 2026; Scott Burell was then appointed chairman.
  • The 2026 annual meeting is expected on November 4, 2026, with a record date of September 15, 2026 and a stockholder proposal deadline of September 10, 2026.
Read the filing on SEC.gov ↗
PCG-PAPACIFIC GAS & ELECTRIC Co Aug 31, 8:00 AM ET

PG&E to hold September 2 investor call on its response to Senate Bill 492

Neutral legal/regulatory Written later 7.01

PG&E Corporation will host a webcast and conference call on September 2, 2026, at 8:30 AM Eastern Time to provide an investor update, including its response to Senate Bill 492. The company said it does not believe the bill adequately addresses financing risks created by California's current wildfire liability framework, and that it falls short of providing the long-term durability needed to attract affordable investment.

  • Investor webcast and conference call set for Wednesday, September 2, 2026, at 8:30 AM Eastern Time
  • Company says Senate Bill 492 does not adequately address financing risks from California's wildfire liability framework
  • Replay available by phone at (800) 770-2030 with confirmation code 92587 through September 9, 2026
Read the filing on SEC.gov ↗
123…5051

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.